Sunday, February 28, 2021
  • Contact
  • Privacy Policy
  • Terms & Conditions
Trends Wide
  • Home
  • News
  • Business
  • Lifestyle
  • Trending
  • Australia
  • Deals
  • Cryptocurrency
No Result
View All Result
Trends Wide
Home Economie

Bristol Myers to acquire MyoKardia for £10 billion

souhaib by souhaib
October 5, 2020
in Economie
0


  • Bristol Myers to acquire MyoKardia for £10 billion or £173.58 per share.
  • The U.S. drugmaker bought Celgene Corp for £57.09 billion last year.
  • Bristol Myers to explore Mavacamten’s potential for other indications.

In an announcement on Monday, Bristol Myers Squibb Co (NYSE: BMY) said it will invest £10 billion to acquire MyoKardia Inc (Nasdaq: MYOK). The deal will help it expand its footprint in the heart drugs business and minimise reliance on cancer treatments.

Bristol Myers remained almost flat in premarket trading on Monday. At £45.32 per share, it is now 7% down as compared to £48.86 per share at the start of 2020. In March, the Coronavirus pandemic had pushed the stock down to as low as £35.80 per share. At the time of writing, Bristol Myers has a market capitalisation of £102.10 billion. Interested in investing in the stock market online? Here’s a simple guide to get you started.


Are you looking for fast-news, hot-tips and market analysis?

Sign-up for the Invezz newsletter, today.

Bristol bought Celgene Corp for £57.09 billion last year

Bristol’s cash offer stands at £173.58 per share that translates to a 61.2% premium on the price at which MyoKardia closed the regular session on Friday. In separate news from the U.S., Caterpillar said on Monday that it will buy Weir Group for a cash deal valued at £312.67 million.

In 2019, Bristol had purchased Celgene Corp for £57.09 billion that was labelled as the largest pharmaceutical deal in history as it merged the world’s top two cancer drug businesses. Earlier this week, Bristol Myers’ drug combination secured approval from the U.S. FDA for Mesothelioma.

Following the completion of the transaction, Bristol Myers will bring Mavacamten under its umbrella – a candidate drug for a chronic heart disease with over 200 thousand patients in Europe and the United States.

As per the sources, MyoKardia will seek approval from the U.S. FDA for its Mavacamten drug next year. If its application is accepted in the first quarter, it will be able to market the drug for chronic heart disease.

Bristol to explore Mavacamten’s potential for other indications

In its statement on Monday, Bristol Myers confirmed its plans of exploring if Mavacamten could be useful for other indications. It will also take over production of MyoKardia’s other drugs that are currently in the pipeline.

MyoKardia is currently exchanging hands at £107.70 per share. Shares of the company have recovered sharply since a year to date low of £34.10 per share in the first week of April. In comparison, MyoKardia had started the year at a per-share price of £55.46.

At the time of writing, the Brisbane-based company has a market cap of £5.71 billion.



Source link

Related posts

Rightmove’s revenue slides 29% in 2020 despite record number of visitors.

February 26, 2021

Salesforce says its full-year revenue topped £14 billion for the first time.

February 26, 2021
Next Post

Weddingstar Washable Cloth Face Mask Reusable and Adjustable Protective Fabric Face Cover w/Dust Filter Pocket - Blush Pink

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

RECOMMENDED NEWS

China’s plan to integrate CBDCs into BSN blockchain right on track

1 month ago

Paul Merson brands former side Arsenal a ‘mid-table team’ and criticises Pierre-Emerick Aubameyang

3 months ago

Salmond and Sturgeon: How the best of political double acts fell apart

3 days ago

Argentina’s health minister forced to resign amid COVID vaccine scandal

1 week ago

BROWSE BY CATEGORIES

  • Australia
  • Cryptocurrency
  • Culture
  • Deals
  • Discounts
  • Economie
  • Euro
  • Gaming
  • Lifestyle
  • News
  • Opinion
  • Sports
  • Switzerland
  • Trending
  • Uncategorized

BROWSE BY TOPICS

2018 League abc Australia Bali United bbc bbc health Budget Travel Champions League Chopper Bike cnn ar business dailymail dailymail australia dailymail heath dailymail money dailymail sport day 7 euronews Health https://lenews.ch/feed/ IGN Istana Negara Market Stories National Exam rt arabic usa today usa today money usa today sport Visit Bali Women Fashion

POPULAR NEWS

  • Watch .. Lebanese astronomer Michel Hayek reveals his predictions for the year 2021

    0 shares
    Share 0 Tweet 0
  • Help save a local business

    0 shares
    Share 0 Tweet 0
  • Love Insurance

    0 shares
    Share 0 Tweet 0
  • 5 places to visit in Microsoft Flight Simulator 2020.

    0 shares
    Share 0 Tweet 0
  • Reece Parkinson: A shock diagnosis won’t stop me running

    0 shares
    Share 0 Tweet 0

Follow us on social media:

Recent News

  • Police narrow down how missing conwoman Melissa Caddick met her grisly end 
  • Doha: The Emir of Qatar called the Saudi Crown Prince
  • Cuomo branded ‘monster’ by NY Democrat amid sexual harassment claims

Category

  • Australia
  • Cryptocurrency
  • Culture
  • Deals
  • Discounts
  • Economie
  • Euro
  • Gaming
  • Lifestyle
  • News
  • Opinion
  • Sports
  • Switzerland
  • Trending
  • Uncategorized

Recent News

Police narrow down how missing conwoman Melissa Caddick met her grisly end 

February 28, 2021

Doha: The Emir of Qatar called the Saudi Crown Prince

February 28, 2021
  • Contact
  • Privacy Policy
  • Terms & Conditions

© 2021 JNews - Premium WordPress news & magazine theme by Jegtheme.

No Result
View All Result
  • Home
  • News
  • Business
  • Culture
  • National
  • Sports
  • Lifestyle
  • Opinion

© 2021 JNews - Premium WordPress news & magazine theme by Jegtheme.